A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer.

BACKGROUND: Cervical cancer is a common leading cause of cancer related to women death worldwide. Cylindromatosis (CYLD) is known as an important tumor suppressor in various human cancers, and a deubiquitination enzyme (DUB) as well. Previously, we identified Skp2 as an E3 ligase of Aurora B ubiquit...

Descripción completa

Detalles Bibliográficos
Publicado en:Clinical Medicine Insights: Oncology Vol. 17; pp. 1 - 12
Autores principales: Yufan Huang, Wei Zhang, Zhihui Yu, Hongkai Su, Bin Zeng, Jinsong Piao, Jing Wang, Juan Wu
Formato: pictorial research tables/charts Journal Article
Publicado: Sage Publications Inc. Jan-Dec2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175226905&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 175226905
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11795549
        B3KT
      jtl: Clinical Medicine Insights: Oncology
      issn: 11795549
      maglogo: Y
    pubinfo:
      dt: Jan-Dec2023
      vid: 17
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        175226905
        175226905
        175226905
        10.1177/11795549231180832
        175226905
      ppf: 1
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer.
      aug:
        au:
          Yufan Huang
          Wei Zhang
          Zhihui Yu
          Hongkai Su
          Bin Zeng
          Jinsong Piao
          Jing Wang
          Juan Wu
        affil: Department of Medical Oncology, Affiliated Cancer Hospital & Cancer Center of Guangzhou Medical University, Guangzhou, China
      sug:
        subj:
          Cervix Neoplasms Prevention and Control
          Cervix Neoplasms Drug Therapy
          Genes, Tumor Suppressor
          Enzymes Therapeutic Use
          Human
          Cell Proliferation
          Chromosomes
          Gene Expression
          Comparative Studies
          Apoptosis
          Cell Migration Assays
          Proteins Analysis
          Immunohistochemistry
          Correlational Studies
          Cell Culture Techniques
          Precipitin Tests
          Fluorescent Antibody Technique
          Virus Diseases
      ab: BACKGROUND: Cervical cancer is a common leading cause of cancer related to women death worldwide. Cylindromatosis (CYLD) is known as an important tumor suppressor in various human cancers, and a deubiquitination enzyme (DUB) as well. Previously, we identified Skp2 as an E3 ligase of Aurora B ubiquitination, but the DUB of Aurora B still remains unknown. METHODS: Aurora B ubiquitination site is identified through in vivo ubiquitination assay. Activity of Aurora B and CENPA was detected by immunoblotting (IB) and immunofluorescence (IF) assay. Protein-to-protein interaction was investigated by immunoprecipitation (IP). Cell chromosome dynamics was monitored by live-cell time-lapse Imaging. Cancer cell proliferation, colony formation, apoptosis, and cell invasion and migration assays were also performed. Protein level was checked by immunohistochemical (IHC) staining in clinical cervical cancer samples. RESULTS: We identified Lysine 115 (K115) as the main Aurora B ubiquitination site for Skp2. We could also detect an interaction of Aurora B with the DUB CYLD. We found that CYLD promoted deubiquitination of Aurora B, and regulated Aurora B activity and function as well. Compared with control, we found it took more time for the cells to finish cell mitosis with CYLD over-expression. Furthermore, we found that CYLD deficiency promoted cervical cancer cell proliferation, colony formation, cell migration and invasion, and inhibited apoptosis instead, whereas it is just opposite with CYLD over-expression. In clinical cervical cancer samples, we showed a negative correlation of CYLD expression with Aurora B activation and histological cancer cell invasion. Furthermore, there was less CYLD abundance and higher Aurora B activity in advanced cancer samples compared with early stage. CONCLUSIONS: Our findings uncover CYLD as a novel potential DUB of Aurora B, which inhibits Aurora B activation and its subsequent function in cell mitosis, and also provide more evidence for its tumor suppressor function in cervical cancer.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N